Aarti Drugs Limited — Call Transcript 2022

Oct 21, 2022

==> picture [560 x 93] intentionally omitted <==

Ref: ADL/SE/2022-23/67 October 21, 2022

To, To, Listing/ Compliance Department Listing/ Compliance Department BSE Limited National Stock Exchange of India Limited, Phiroze Jeejeebhoy Towers, “Exchange Plaza”, Plot No. C/1, Dalal Street, G Block Bandra - Kurla Complex, Mumbai – 400 001 Bandra (East), Mumbai – 400051 BSE CODE: 524348 NSE SYMBOL: AARTIDRUGS Dear Sir/Madam,

Sub: Recording of Conference Call Ref: Regulation 30 of SEBI (LODR) Regulations, 2015

In continuation to our letter dated October 17, 2022 regarding intimation of Investors/ Analyst conference call on the Financial Results of the Company for the quarter and half year ended September 30, 2022, we would like to inform you that the audio recording of the said call has been uploaded on the Company’s website. This can be accessed via the following link.

Link: https://www.aartidrugs.co.in/concall-recording/

The transcript for the said call will be shared with the Stock Exchanges and will also be uploaded on the Company’s website (https://www.aartidrugs.co.in/) in due course.

This is for your information and record.

Thanking you,

Yours faithfully,

FOR AARTI DRUGS LIMITED RUSHIKESH VIVEK DEOLE Digitally signed by RUSHIKESH VIVEK DEOLE DN: c=IN, o=PERSONAL, title=5599, pseudonym=52288d43536c4230831c2e75cd4b8c59, 2.5.4.20=073813c4edff683f8b6ec3cb4e69ca6d8d4f7258a44f635abc18581eaa522821, postalCode=421301, st=Maharashtra, serialNumber=9b60f64457feab7f455d17463ebe710861bf01b575f6fc0484483273dabfc17f, cn=RUSHIKESH VIVEK DEOLE Date: 2022.10.21 17:21:29 +05'30'

RUSHIKESH DEOLE COMPANY SECRETARY & COMPLIANCE OFFICER ICSI M. No.: A54527

==> picture [451 x 30] intentionally omitted <==